Sonia Philipose

452 total citations
12 papers, 387 citations indexed

About

Sonia Philipose is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Sonia Philipose has authored 12 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Physiology. Recurrent topics in Sonia Philipose's work include Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Asthma and respiratory diseases (3 papers). Sonia Philipose is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Asthma and respiratory diseases (3 papers). Sonia Philipose collaborates with scholars based in Austria and India. Sonia Philipose's co-authors include Rufina Schuligoi, Ákos Heinemann, Viktória Kónya, Bernhard A. Peskar, Gunther Marsche, Eva M. Sturm, Irmgard Th. Lippe, Maria Waldhoer, Petra Luschnig and Stefan Gattenlöhner and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Sonia Philipose

12 papers receiving 381 citations

Peers

Sonia Philipose

PHARM

PHYSI

IMMUN

SURGE

Thomas Bärnthaler Austria

Yee‐Ping Sun United States

Antonio Morelli Italy

Robin MacLaren Canada

Xiao Lei Moore Australia

Ze Bo Hu China

Scott Worthen United States

CN Serhan United States

Maria Ruart Spain

Lucy Bailey United Kingdom

Thomas Bärnthaler Austria

Sonia Philipose

71 ×0.6

PHARM

135 ×1.1

PHYSI

183 ×2.1

90 ×1.2

IMMUN

69 ×1.1

SURGE

Citations per year, relative to Sonia Philipose Sonia Philipose (= 1×) peers Thomas Bärnthaler

Countries citing papers authored by Sonia Philipose

Since Specialization

Citations

This map shows the geographic impact of Sonia Philipose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Philipose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Philipose more than expected).

Fields of papers citing papers by Sonia Philipose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Philipose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Philipose. The network helps show where Sonia Philipose may publish in the future.

Co-authorship network of co-authors of Sonia Philipose

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Philipose. A scholar is included among the top collaborators of Sonia Philipose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Philipose. Sonia Philipose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Pasterk, Lisa, Sonia Philipose, Kathrin Eller, et al.. (2015). The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions. Pharmacology. 96(3-4). 137–143. 11 indexed citations

Birner‐Gruenberger, Ruth, Tatjana Stojaković, Hubert Scharnagl, et al.. (2013). Distinct composition of human fetal HDL attenuates its anti-oxidative capacity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(4). 737–746. 49 indexed citations

Kónya, Viktória, Anna Theiler, Sonia Philipose, et al.. (2012). Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking. Journal of Allergy and Clinical Immunology. 131(2). 532–540.e2. 48 indexed citations

Philipose, Sonia, Viktória Kónya, Lisa Pasterk, et al.. (2012). Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation. PLoS ONE. 7(8). e40222–e40222. 10 indexed citations

Philipose, Sonia, Viktória Kónya, Lisa Pasterk, et al.. (2012). Laropiprant attenuates EP3and TP prostanoid receptor-mediated thrombus formation. BMC Pharmacology and Toxicology. 13(S1). 1 indexed citations

Sturm, Eva M., Viktória Kónya, Sonia Philipose, et al.. (2011). EP4 receptor stimulation down-regulates human eosinophil function. Cellular and Molecular Life Sciences. 68(21). 3573–3587. 51 indexed citations

Mishra, Pooja, et al.. (2011). Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory. Journal of Negative Results in BioMedicine. 10(1). 16–16. 5 indexed citations

Kónya, Viktória, Sonia Philipose, Zoltán Bálint, et al.. (2011). Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors. European Journal of Immunology. 41(8). 2379–2389. 30 indexed citations

Schuligoi, Rufina, Eva M. Sturm, Petra Luschnig, et al.. (2010). CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases. Pharmacology. 85(6). 372–382. 88 indexed citations

10.

Philipose, Sonia, et al.. (2010). A biological target for antiplatelet therapy: the prostaglandin E2 receptor EP4. BMC Pharmacology. 10(S1). 19 indexed citations

11.

Philipose, Sonia, Viktória Kónya, Gunther Marsche, et al.. (2010). The Prostaglandin E₂Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation. Arteriosclerosis Thrombosis and Vascular Biology. 30(12). 2416–2423. 73 indexed citations

12.

Philipose, Sonia, et al.. (2009). Prostaglandin E2 acts via the EP4 receptor to inhibit platelet aggregation. BMC Pharmacology. 9(S2). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact